Trials / Recruiting
RecruitingNCT07467083
Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for Head and Neck Cancer Patients Undergoing Radiation Therapy
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 170 (estimated)
- Sponsor
- West China Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate whether a nurse-led preemptive symptom management protocol can reduce the radiation therapy interruption rate in patients with head and neck cancer compared to conventional care models.
Detailed description
The aim of this study is to investigate whether a nurse-led preemptive symptom management protocol can reduce the radiation therapy interruption rate in patients with head and neck cancer compared to conventional care models. The secondary objective is to evaluate whether the nurse-led preemptive symptom management protocol improves symptoms, quality of life, and psychological well-being in head and neck cancer patients undergoing radiation therapy compared to conventional care models.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Nurse-led preemptive symptom management | The intervention encompasses four key components: symptom monitoring and management guided by a standardized manual, emotional and psychological support integrating family involvement and traditional cultural values, family-unit-based education and skills training, and care coordination ensuring multidisciplinary communication. |
| BEHAVIORAL | Concentional care | Conventional care encompasses basic nursing care and routine health education, including instruction related to radiotherapy. |
Timeline
- Start date
- 2026-03-15
- Primary completion
- 2027-03-01
- Completion
- 2027-03-01
- First posted
- 2026-03-12
- Last updated
- 2026-04-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07467083. Inclusion in this directory is not an endorsement.